SK4732000A3 - Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate - Google Patents

Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate Download PDF

Info

Publication number
SK4732000A3
SK4732000A3 SK473-2000A SK4732000A SK4732000A3 SK 4732000 A3 SK4732000 A3 SK 4732000A3 SK 4732000 A SK4732000 A SK 4732000A SK 4732000 A3 SK4732000 A3 SK 4732000A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
alkyl
phenyl
substituted
Prior art date
Application number
SK473-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Benjamin R P Stone
Luigi Anzalone
Joseph M Fortunak
Gregory D Harris
Ioannis I Valvis
Robert E Waltermire
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of SK4732000A3 publication Critical patent/SK4732000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK473-2000A 1997-10-06 1998-10-06 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate SK4732000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6119597P 1997-10-06 1997-10-06
PCT/US1998/021051 WO1999018085A2 (en) 1997-10-06 1998-10-06 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

Publications (1)

Publication Number Publication Date
SK4732000A3 true SK4732000A3 (en) 2001-03-12

Family

ID=22034252

Family Applications (1)

Application Number Title Priority Date Filing Date
SK473-2000A SK4732000A3 (en) 1997-10-06 1998-10-06 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

Country Status (19)

Country Link
US (2) US6218534B1 (et)
EP (1) EP1025092A2 (et)
JP (1) JP2001519335A (et)
KR (1) KR20010024403A (et)
CN (1) CN1273586A (et)
AR (1) AR017763A1 (et)
AU (1) AU9788198A (et)
BR (1) BR9815400A (et)
CA (1) CA2304513A1 (et)
EE (1) EE200000157A (et)
HR (1) HRP980538A2 (et)
HU (1) HUP0003933A3 (et)
IL (1) IL135470A0 (et)
NO (1) NO20001749L (et)
PL (1) PL340238A1 (et)
SK (1) SK4732000A3 (et)
TW (1) TW505649B (et)
WO (1) WO1999018085A2 (et)
ZA (1) ZA989099B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449111B2 (en) * 2003-07-30 2008-11-11 Arkema Inc. Resins containing ionic or ionizable groups with small domain sizes and improved conductivity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5530124A (en) 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5532356A (en) 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
US5998614A (en) * 1997-07-07 1999-12-07 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas using an alkali metal in liquid ammonia process

Also Published As

Publication number Publication date
HRP980538A2 (en) 1999-10-31
EE200000157A (et) 2001-02-15
US20010020093A1 (en) 2001-09-06
KR20010024403A (ko) 2001-03-26
WO1999018085A3 (en) 1999-06-24
AR017763A1 (es) 2001-10-24
NO20001749L (no) 2000-06-05
JP2001519335A (ja) 2001-10-23
BR9815400A (pt) 2001-09-25
HUP0003933A3 (en) 2001-12-28
US6452000B2 (en) 2002-09-17
PL340238A1 (en) 2001-01-29
TW505649B (en) 2002-10-11
EP1025092A2 (en) 2000-08-09
ZA989099B (en) 2000-04-06
CA2304513A1 (en) 1999-04-15
CN1273586A (zh) 2000-11-15
NO20001749D0 (no) 2000-04-05
US6218534B1 (en) 2001-04-17
HUP0003933A2 (hu) 2001-10-28
WO1999018085A2 (en) 1999-04-15
AU9788198A (en) 1999-04-27
IL135470A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
US5932726A (en) Asymmetric synthesis of benzoxazinones
JP2001519810A (ja) 新規中間体を経由するベンゾオキサジノン類の不斉合成
RU2621725C2 (ru) Способ получения 1-([1,3]диоксолан-4-илметил)-1н-пиразол-3-иламина
CA2857969A1 (en) (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
AU2012270017A1 (en) Improved process for preparing cyclopentylamine derivatives and intermediates thereof
US20100137592A1 (en) Process for preparing purine derivative
JP3786834B2 (ja) 新規6−(4−フエニルブトキシ)ヘキシルアミン誘導体およびサルメテロールの製法
SK4732000A3 (en) Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
HU222038B1 (hu) Eljárás norbenzomorfánszármazékok előállítására
KR101874659B1 (ko) 이민 수소화로써의 치환된 n-(벤질)시클로프로판아민의 제조 방법
JP3245578B2 (ja) ピロリジニルヒドロキサム酸化合物の製造方法
CZ20001127A3 (cs) Způsob výroby nesymetrických cyklických močovin přes monoacylované diaminové meziprodukty
MXPA00003328A (en) Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
KR100850558B1 (ko) 아토르바스타틴의 효율적인 제조방법
JP2003171354A (ja) 光学活性アミン化合物又はその塩の製造方法
WO2024042119A1 (en) Process for the preparation of substituted pyrrolopyrimidines and intermediates
EP2152697A2 (en) Process for the preparation of alfuzosin and salts thereof
JP2003026672A (ja) 3−アミノオキセタンの新規製造法並びに中間体
WO2014083150A1 (en) Preparation of 3-amino-piperidine compounds via nitro-tetrahydropyridine precursors
JP2002053536A (ja) スピロアミノピロリジン誘導体およびその製造法
SK121999A3 (en) Process for the preparation of terbinafine and an intermediate of its preparation of e-isomer (e)-n-(3-chloro-2-propenyl)-n- -methyl-1-naphtalene methylamine tosylate salt